Welcome to the WCN 2023 Interactive Program

Session Description:The global incidence and prevalence of demyelinating diseases are increasing. Diagnosis criteria were revised within the last few years. Differential diagnoses vary widely according to the clinical presentation and the demographic and geographical context. The therapeutic approach depends on the etiology, the disease phenotype and the available healthcare ressources. A standardized diagnostic approach and treatment recommendations are needed to guide demyelinating diseases’ management.Learning Objectives:1. To have an overview on the epidemiology of demyelinating diseases worldwide2. To conduct a complete diagnosis approach leading to the diagnosis of MS and NMOSD3. To assess the possible therapeutic choices to treat demyelinating diseases worldwide